View the Brochure 

Sign-up for email updates

TARGET AUDIENCE 

Hematologists and Medical Oncologists, Hematology Residents and Fellows, Members of the Allied Health Care team involved in the care of blood and marrow transplant patients. 

LEARNING OBJECTIVES 

By attending this activity, participants will be able to: 

• Understand cytogenetic and molecular testing and how the results impact prognosis and transplant decision making. 
• Identify and manage complications of transplant and cellular therapy including regimen related toxicity, graft vs. host disease and infection. 
• Discuss the role of CAR T-cells as an emerging therapy for hematologic malignancies. 
• Review pharmacologic and non-pharmacologic supportive care for transplant patients.